AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications

"Mr. Anthony Hayes, CEO of AIkido, stated, "We are excited to explore this aspect of cancer treatment. Our license covers the use of psilocybin to treat both cancer and cancer side-effects and we believe this to be an expanding area for treatment."

010721 AIkido Pharma Inc

. Executes Licen

Download EXECUTES LICEN • 61KB